Home > M&A deals 2026 > Linden Capital Partners LLC and 2 others acquire ArtesRx LLC
Secondary Buyout · Life Science · August 2026

Linden Capital Partners LLC and 2 others acquire ArtesRx LLC

On August 24, 2026, Linden Capital Partners LLC, Antares Capital Corp. and MidCap Financial LLC acquired ArtesRx LLC, a life science company in New York, United States, from Flexpoint Ford LLC. Houlihan Lokey advised on the deal.

Deal at a glance

AnnouncedAugust 24, 2026 TypeSecondary Buyout TargetArtesRx LLC Buyers Linden Capital Partners LLC
Antares Capital Corp.
MidCap Financial LLC
Seller Flexpoint Ford LLC SectorLife Science LocationNew York, United States ValueNot disclosed Advisors Houlihan Lokey Bank

Target company

ArtesRx LLC
New York, United States
ArtesRx LLC is a U.S.-based pharmacy services company that acquires, operates, and supports pharmacies serving patients with complex medication needs, with a particular focus on behavioral health, substance use disorders, intellectual and developmental disa...
Life Sciencesector
2023founded
Activestatus
View the company profile →

Buyers (3)

Private equity firm · 44 deals on record
Private equity firm · 79 deals on record
Company · 4 deals on record
  • 5th transaction for the lead buyer in life science
  • 43rd transaction in United States
44deals, all time
5in this sector
2026latest

Seller

Private equity firm · 50 deals on record
50investments
4in this sector
16exits

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
Firefly Bio, Inc.Same sector and country · Jul 2026
Personalis, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired ArtesRx LLC?Linden Capital Partners LLC, Antares Capital Corp. and MidCap Financial LLC acquired ArtesRx LLC on August 24, 2026.

Who sold ArtesRx LLC?Flexpoint Ford LLC was the seller.

Who advised on the ArtesRx LLC deal?Houlihan Lokey advised on the deal.

What type of deal was it?It was a secondary buyout in the life science sector in 2026.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Source: company press release, August 24, 2026 · Data updated daily on AcquityData (Acquity Data).